Offer - Urjas Oil for just ₹ 1
Mefomin 500 SR Tablet is a prescription medicine that is available as a Tablet. Diabetes are some of its major therapeutic uses.
The optimal dosage of Mefomin 500 SR Tablet is largely dependent on the individual's body weight, medical history, gender and age. Individual symptoms and route of administration also determines the right dosage. Detailed information has been provided in the dosage section.
The side effects typically associated with Mefomin 500 SR Tablet include Stomach Upset, Difficulty urinating. Besides the aforementioned side effects, there are other adverse effects of Mefomin 500 SR Tablet as well, which are listed below. Such side effects of Mefomin 500 SR Tablet normally do not last long and go away once the treatment is completed. If, however, they worsen or do not go away, please speak with your physician.
Mefomin 500 SR Tablet's effect during pregnancy is Mild and Moderate while nursing. Further, the section on Mefomin 500 SR Tablet related warnings talks about Mefomin 500 SR Tablet's effects on the liver, heart and kidney.
Individuals suffering from medical conditions like Congestive Heart Failure (CHF), Anemia, Shock must refrain from the use of Mefomin 500 SR Tablet since this can cause severe adverse effects. Other contraindications of Mefomin 500 SR Tablet have been discussed in the sections ahead.
Additionally, Mefomin 500 SR Tablet may also adversely react with other medicines. See below for a complete list.
You should also be aware that Mefomin 500 SR Tablet is safe while driving, and is addiction.
Mefomin 500 SR Tablet is used to treat the following -
Main Benefits
This is the usual dosage recommended in most common treatment cases. Please remember that every patient and their case is different, so the dosage can be different based on the disease, route of administration, patient's age and medical history.
Find the right dosage based on disease and age
Age Group | Dosage |
Adult |
|
Geriatric |
|
13 - 18 years (Adolescent) |
|
2 - 12 years (Child) |
|
Based on research, the following side effects have been observed when Mefomin 500 SR Tablet is used -
Severe
Moderate
Mild
Common
Is the use of Mefomin 500 SR Tablet safe for pregnant women?
Mefomin has mild to no side effects in pregnant women.
Is the use of Mefomin 500 SR Tablet safe during breastfeeding?
Mefomin may lead to some side effects in breastfeeding women. If you witness any unusal symptoms after taking Mefomin, discontinue its use and call your doctor right away. Follow your doctor's advice regarding the use of Mefomin.
What is the effect of Mefomin 500 SR Tablet on the Kidneys?
Mefomin is not harmful for kidneys.
What is the effect of Mefomin 500 SR Tablet on the Liver?
Mefomin does not damage the liver.
What is the effect of Mefomin 500 SR Tablet on the Heart?
Using Mefomin does not have any harmful effects on the heart.
Mefomin 500 SR Tablet should not be taken with following medicines due to severe side effects it may cause to patients -
Severe
Moderate
If you are suffering from any of the following diseases, you should not take Mefomin 500 SR Tablet unless your doctor advises you to do so -
Is this Mefomin 500 SR Tablet habit forming or addictive?
Mefomin 500 SR Tablet is not addictive in nature.
Is it safe to drive or operate heavy machinery when consuming?
Mefomin 500 SR Tablet will not make you feel sleepy or drowsy. So you drive or operate machinery safely.
Is it safe?
Yes, but take Mefomin 500 SR Tablet only as per medical advice.
Is it able to treat mental disorders?
No, Mefomin 500 SR Tablet is not used to treat mental disorders.
Interaction between Food and Mefomin 500 SR Tablet
Information is not available on the interaction of any foods with Mefomin 500 SR Tablet, due to a lack of research on this.
Interaction between Alcohol and Mefomin 500 SR Tablet
Consuming Mefomin 500 SR Tablet with alcohol can have many serious effects on your body.
Lactic acidosis associated with Mefomin treatment is a rare but fatal adverse effect. Lactic acidosis appears to result from biguanide interference causing an increase in production and decrease in clearance of lactate leading to higher cellular lactate levels. A decrease in pyruvate carboxylase activity, the rate-limiting enzyme in the formation of glucose from lactate, can also decrease hepatic metabolism of lactate. leading to increasing lactic acidosis. Signs and symptoms of Mefomin induced lactic acidosis are nonspecific and include anorexia, nausea, vomiting, altered level of consciousness, hyperpnoea, abdominal pain, and thirst.
Yes, Mefomin can cause night sweat, the exact mechanism of sweating is not known. But some research suggests that Mefomin causes hypoglycemia (low blood sugar) especially at night which can cause night sweats. Need to monitor your blood glucose level regularly, and talk to your doctor as your dose of Mefomin may need to be adjusted.
Yes, Mefomin can cause low blood sugar (hypoglycemia). However, this can also occur if you delay or miss a meal, drink alcohol, exercise more than usual, can't eat due to stomach upset, and taking other antidiabetic medicine with metformin. So, regular monitoring of blood glucose level is needed and be cautious of symptoms of hypoglycemia, always keep glucose-rich food with you.
Mefomin helps in weight loss by reducing appetite and food intake. It also increases the insulin sensitivity in your body to work more effectively. This lead to decreased glucose production increases the use of glucose and decrease the fat deposition further helps in weight loss. However, Mefomin is not approved for weight loss, this is an off-label use.
Mefomin works by decreasing the hepatic glucose production. It also works to lower blood sugar by increasing your sensitivity to insulin and decreasing the amount of glucose that is absorbed from the food you eat.
This medicine data has been created by -
References
US Food and Drug Administration (FDA) [Internet]. Maryland. USA; Package leaflet information for the user; Glucophage® (metformin hydrochloride)
KD Tripathi. [link]. Seventh Edition. New Delhi, India: Jaypee Brothers Medical Publishers; 2013: Page No 275-276
April Hazard Vallerand, Cynthia A. Sanoski. [link]. Sixteenth Edition. Philadelphia, China: F. A. Davis Company; 2019: Page No 825-826